Table 1 Clinical and metabolic parameters of MetS, Obese and control groups
From: Serum prolidase activity is associated with non-diabetic metabolic syndrome
MetS (n = 34, 31M and 3F) | Obese (n = 30, 28M and 2F) | Control (n = 23, 20M and 3F) | |
|---|---|---|---|
Age (years) | 35.18 ± 6.8 | 33.67 ± 7.9 | 32.39 ± 4.7 |
Body weight (kg) | 97.27 ± 12.6b,f | 92.07 ± 19.2c | 60.30 ± 10.3 |
BMI (kg/m2) | 38.91 ± 5.5b | 36.59 ± 5.2c | 22.93 ± 3.4 |
Waist-C (cm) | 106.85 ± 10.3b,f | 99.73 ± 13.2c | 75.52 ± 8.1 |
SBP (mmHg) | 136.77 ± 12.0a,b | 118.67 ± 13.1c | 105.65 ± 7.7 |
DBP (mmHg)* | 90(70–110)a,b | 80(70–100)c | 60(50–80) |
TC (mg/dl) | 194.39 ± 35.6e | 181.66 ± 24.2 | 168.13 ± 24.7 |
HDL (mg/dl) | 44.39 ± 13.3b | 42.14 ± 9.9 | 55.65 ± 5.2 |
TG (mg/dl) | 174.91 ± 72.9a,b | 100.07 ± 35.3 | 73.44 ± 30.6 |
LDL (mg/dl) | 113.68 ± 37.4 | 117.76 ± 23.4h | 97.80 ± 21.9 |
TOS (mmol H2O2 Equiv./l) | 13.94 ± 2.19e,f | 12.74 ± 2.1 | 13.05 ± 2.3 |
TAS (mmol Trolox Equiv./l) | 0.95 ± 0.1a,b | 1.10 ± 0.1h | 1.16 ± 0.1 |
OSI (arbitrary unit) | 14.67 ± 2.2a,b | 11.48 ± 2.3 | 10.65 ± 2.4 |
FPG (mg/dl) | 102.88 ± 13.3b | 97.94 ± 7.4h | 90.87 ± 9.8 |
Prolidase | 708.93 ± 10.4b,f | 703.17 ± 8.1h | 696.69 ± 11.5 |